Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Bioxytran, Inc. (BIXT) had Stock-Based Compensation of $0.26M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-0.28M |
|
-- |
|
-- |
|
$0.50M |
|
$-0.50M |
|
$0.21M |
|
$-0.28M |
|
$-0.28M |
|
$-0.28M |
|
$-0.28M |
|
$-0.28M |
|
$-0.28M |
|
$-0.50M |
|
$-0.49M |
|
88.99M |
|
88.99M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.01M |
|
-- |
|
$0.14M |
|
$0.16M |
|
$3.06M |
|
-- |
|
-- |
|
$3.06M |
|
$-2.96M |
|
$-3.05M |
|
$-2.90M |
|
88.99M |
|
| Cash Flow Statement Financials | |
$-0.29M |
|
$-0.02M |
|
$0.32M |
|
$0.01M |
|
$0.01M |
|
$0.01M |
|
|
Stock-Based Compensation |
$0.26M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.29 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
9.55% |
|
9.28% |
|
-180.89% |
|
9.73% |
|
$-0.03 |
|
$-0.00 |
|
$-0.00 |
|